Ian Pitfield
Chief Tech/Sci/R&D Officer bei GYROSCOPE THERAPEUTICS HOLDINGS PLC
Profil
Ian Pitfield is a professional who has worked as the Head of Cell & Gene Therapy Medicine at GSK Plc from 1993 to 2016.
Currently, he is the Senior Vice President-Technical Operations at Gyroscope Therapeutics Holdings Plc since 2020.
Dr. Pitfield holds a doctorate degree from the University of Cambridge.
Aktive Positionen von Ian Pitfield
| Unternehmen | Position | Beginn |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01.07.2020 |
Ehemalige bekannte Positionen von Ian Pitfield
| Unternehmen | Position | Ende |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01.12.2016 |
Ausbildung von Ian Pitfield
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
